Alpha Teknova, Inc. (TKNO)

NASDAQ: TKNO · IEX Real-Time Price · USD
15.77 -0.54 (-3.31%)
Jan 18, 2022 4:00 PM EST - Market closed
Market Cap441.75M
Revenue (ttm)36.94M
Net Income (ttm)-6.06M
Shares Out28.01M
EPS (ttm)-0.61
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume35,266
Open16.02
Previous Close16.31
Day's Range15.32 - 16.80
52-Week Range15.00 - 30.89
Betan/a
AnalystsStrong Buy
Price Target29.33 (+86.0%)
Earnings DateNov 10, 2021

About TKNO

Alpha Teknova, Inc. provides reagents for bioprocessing, bioproduction, and molecular diagnostics. The company's reagents enable the discovery, research, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. It offers liquid culture, dry culture, agar, and animal-free media, as well as pre-poured plates, biological buffers, solutions, chemicals, and various treated and certified waters. The company was founded in 1996 and is based in Hollister, California.

IndustryDrug Manufacturers-Specialty & Generic
IPO DateJun 25, 2021
Employees183
Stock ExchangeNASDAQ
Ticker SymbolTKNO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for Alpha Teknova stock is "Strong Buy." The 12-month stock price forecast is 29.33, which is an increase of 85.99% from the latest price.

Price Target
$29.33
(85.99% upside)
Analyst Consensus: Strong Buy

News

Teknova to Join the Nasdaq Biotechnology Index

HOLLISTER, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical produ...

1 month ago - GlobeNewsWire

Teknova to Participate in Upcoming Investor Conferences

HOLLISTER, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical produ...

2 months ago - GlobeNewsWire

Teknova Reports Third Quarter 2021 Financial Results

$9.4 million in total revenue, up 5% year-over-year Excluding Sample Transport, total revenue was $9.3 million, up 26% year-over-year Strong cash position of $98.0 million supports investment in long-te...

2 months ago - GlobeNewsWire

Teknova to Report Third Quarter 2021 Financial Results on November 10, 2021

HOLLISTER, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical produ...

2 months ago - GlobeNewsWire

Teknova Reports Second Quarter 2021 Financial Results

—$8.3 million in total revenue, up 38% year-over-year—

5 months ago - GlobeNewsWire

Teknova Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additi...

HOLLISTER, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical produ...

6 months ago - GlobeNewsWire

Teknova Announces Pricing of its Upsized Initial Public Offering

HOLLISTER, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical produ...

6 months ago - GlobeNewsWire